NCT00848484 Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00847600 Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia Status COMPLETED Phase PHASE4
NCT00845572 The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center Status COMPLETED Phase NA
NCT00845026 A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients Status COMPLETED Phase PHASE2
NCT00843687 A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients. Status COMPLETED Phase PHASE3
NCT00839852 A Study of Cariprazine in Patients With Chronic Stable Schizophrenia Status COMPLETED Phase PHASE2
NCT00838669 A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone Status COMPLETED Phase PHASE1
NCT00838227 Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder Status WITHDRAWN Phase PHASE2
NCT00838123 Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia Status COMPLETED Phase N/A
NCT00836251 Effects of Antipsychotic Medications on Energy Intake and Expenditure Status COMPLETED Phase N/A
NCT00833976 Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia Status COMPLETED Phase PHASE4
NCT00833547 Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia Status COMPLETED Phase NA
NCT00833456 NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT00832845 Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study Status COMPLETED Phase NA
NCT00828958 Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients. Status COMPLETED Phase PHASE3
NCT00827918 A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004) Status COMPLETED Phase PHASE2
NCT00827840 Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00825539 Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2